静脈システムアクセス機器市場：デバイスタイプ、技術、用途、エンドユーザー別-2025-2030年の世界予測

静脈システムアクセス機器市場の2023年の市場規模は45億4,000万米ドルで、2024年には48億3,000万米ドルに成長し、CAGRは6.50%、2030年には70億6,000万米ドルに達すると予測されています。

進化を続けるヘルスケアにおいて、点滴システムアクセス機器は、効果的な患者ケアを促進する極めて重要なコンポーネントとして浮上しています。本レポートでは、これらのデバイスの役割を再定義した市場力学を掘り下げ、技術の進歩、規制の変化、進化する患者のニーズの相互作用に焦点を当てています。過去10年間で、慢性疾患の増加、低侵襲処置の需要、ヘルスケアサービスの拡大が、この分野の大幅な技術革新を推進しました。

これらの機器が治療成績の向上にどのように貢献するかを理解するには、技術的および臨床的な意味を理解することが不可欠です。この包括的な分析では、患者の安全性、業務効率、費用対効果に焦点を当て、現在の市場動向、新たなイノベーション、これらの機器の戦略的重要性に関する洞察を提供します。市場の成熟が進むにつれ、利害関係者は臨床的有効性と操作の容易さのバランスを取ることを求められており、現代のヘルスケア診療において統合性の高い静脈アクセスソリューションが不可欠であることをさらに強調しています。

以下のセクションでは、市場環境の変化、詳細なセグメンテーション、地域別市場動向について詳しく解説します。これにより、業界リーダーが来るべき機会を十分に活用できるよう、実行可能な提言のロードマップを提供します。

静脈アクセス機器市場を形成する変革的変化

近年、静脈アクセス装置市場は、業界のパラメータを再定義するような変革的な変化を経験しています。技術の飛躍的進歩は、メーカーに、より安全で効果的なだけでなく、複雑化する現代医療に対応するオーダーメイドの機器を開発するツールを提供しました。先進素材、スマート・モニタリング・システム、デジタル・インターフェースの統合により、患者のリアルタイム・モニタリングが容易になり、合併症が減少し、臨床転帰が向上しました。

この進化は、規制上の優遇措置と患者中心の医療への世界の焦点に支えられた研究開発活動の急増によって、さらに後押しされています。ヘルスケア機関や医療提供者は、診断データを治療結果に結びつける統合的なアプローチをますます採用するようになっており、それによってすべての機器が臨床的な正確さとシームレスな使いやすさの両方をサポートするようになっています。このような状況の変化に伴い、メーカー各社は継続的な技術革新を求められ、安全性、性能、コンプライアンスにおいて常に時代の先端を行く製品を提供することが求められています。このダイナミックな環境は競合へのプレッシャーを高めるだけでなく、業界関係者間のコラボレーションを促進し、イノベーションが繁栄し、市場標準が継続的に向上するエコシステムを育んでいます。

こうした要因の融合は、急速な技術革新と進化する患者ケアプロトコルに対応した持続可能なヘルスケアソリューションへの幅広いシフトを浮き彫りにしています。

戦略的優位性を促進する市場セグメンテーションアプローチに関する主要な洞察

この市場調査では、利害関係者が成長機会を正確に把握し、多様な臨床要件に合わせたソリューションを提供できるようにするセグメンテーション戦略を厳密に調査しています。主要なセグメンテーションの1つはデバイスタイプに基づくもので、市場は中心静脈アクセスと末梢静脈アクセスにわたって包括的に調査されています。中心静脈アクセスカテゴリーでは、埋め込み型デバイス、非トンネル型カテーテル、末梢挿入型中心静脈アクセスカテーテル、トンネル型中心静脈アクセスカテーテル、カフ型中心静脈アクセスカテーテルによって差別化が図られています。末梢カテゴリーでは、広く使用されているPIVカテーテルとともに正中線カテーテルが検討されます。

その他のセグメンテーションでは、システムを閉鎖型、統合型、開放型プラットフォームに分類することで技術的側面を検証し、それぞれの技術的ニュアンスが臨床的な要求と一致していることを確認します。さらに、用途別のセグメンテーションでは、輸血、診断検査、薬物投与、輸液・栄養補給など、さまざまな臨床用途を網羅しており、臨床現場における装置の多用途性を反映しています。最後に、エンドユーザー別のセグメンテーションは、外来手術センター、長期介護施設を含む在宅介護の現場、病院や診療所などでのバリエーションを考慮したものです。このような多層的なセグメンテーション・アプローチにより、市場行動に対する深い洞察が得られ、特定の臨床上および業務上の課題に対処するために実施可能なオーダーメイドの戦略が浮き彫りになります。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で慢性疾患の罹患率が増加
    • 急成長する外来・在宅ヘルスケアサービス
    • 発展途上地域における医療ツーリズムの増加
  • 抑制要因
    • 高度な静脈システムアクセス機器と製品リコールに関連する高コスト
  • 機会
    • ヘルスケア提供者とメーカー間の戦略的提携
    • 低侵襲手術における技術革新
  • 課題
    • 厳格な規制方針と承認要件、そして限定的な償還
• 市場セグメンテーション分析
  • デバイスタイプ：多用途性と短期治療における使いやすさが、末梢静脈アクセスの使用を促進します。
  • テクノロジー：ヘルスケア提供の効率性を改善し、患者の安全性を高める高度な機能が統合システムの導入を推進
  • 応用：現代のヘルスケアにおけるIV薬剤投与の重要性
  • エンドユーザー：病院や診療所における幅広い医療処置や処置における重要な役割により、静脈システムアクセス機器の必要性が高まっています。
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 静脈システムアクセス機器市場：デバイスタイプ別

• 中心静脈アクセス
  • 埋め込み型デバイス
  • 非トンネル型カテーテル
  • 末梢挿入型中心静脈カテーテル
  • トンネル型カフ付き中心静脈カテーテル
• 末梢静脈アクセス
  • 正中線カテーテル
  • PIVカテーテル

第7章 静脈システムアクセス機器市場：技術別

• 閉鎖系
• 統合システム
• オープンシステム

第8章 静脈システムアクセス機器市場：用途別

• 輸血
• 診断検査
• 医薬品管理局
• 水分と栄養補給

第9章 静脈システムアクセス機器市場：エンドユーザー別

• 外来手術センター
• 在宅ケア施設と長期ケア施設
• 病院と診療所

第10章 南北アメリカの静脈システムアクセス機器市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の静脈システムアクセス機器市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの静脈システムアクセス機器市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析, 2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Access Vascular, Inc.
• Angiplast Private Limited
• Argon Medical Devices, Inc.
• B. Braun SE
• Baxter International Inc.
• Becton, Dickinson and Company
• Delta Med S.p.A.
• Disposafe Health and Life Care Ltd.
• FAS United Medical Company
• Fresenius SE & Co. KGaA
• Hangzhou Fushan Medical Appliances Co., LTD.
• Harsoria Healthcare Pvt Ltd
• I-V Access Technology, Inc.
• ICU Medical, Inc. by Otsuka Holdings Co. Ltd.
• Kimal PLC
• Medilivescare Manufacturing Private Limited
• Medivac Surgical Pvt. Ltd.
• Medtronic PLC
• Narang Medical Limited
• Ningbo GreatCare Trading Co., Ltd.
• Nipro Corporation
• Poly Medicure Limited
• Teleflex Incorporated
• Terumo Corporation
• Vygon SAS

LIST OF FIGURES

• FIGURE 1. INTRAVENOUS SYSTEM ACCESS DEVICES MARKET MULTI-CURRENCY
• FIGURE 2. INTRAVENOUS SYSTEM ACCESS DEVICES MARKET MULTI-LANGUAGE
• FIGURE 3. INTRAVENOUS SYSTEM ACCESS DEVICES MARKET RESEARCH PROCESS
• FIGURE 4. INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 5. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. INTRAVENOUS SYSTEM ACCESS DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. INTRAVENOUS SYSTEM ACCESS DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY NON-TUNNELED CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TUNNELED & CUFFED CENTRAL CATHETER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MIDLINE CATHETER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PIV CATHETER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY OPEN SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DRUG ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY FLUID & NUTRITIONAL SUPPORT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOMECARE SETTINGS & LONG-TERM CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. CANADA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 51. CANADA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 52. CANADA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 53. CANADA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. CANADA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. CANADA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 83. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 84. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 85. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. CHINA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. INDIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 89. INDIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 90. INDIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 91. INDIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. INDIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. INDIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 191. ITALY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 192. ITALY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 193. ITALY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 194. ITALY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 195. ITALY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. ITALY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 215. POLAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 216. POLAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 217. POLAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 218. POLAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 219. POLAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 220. POLAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 221. QATAR INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 222. QATAR INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 223. QATAR INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 224. QATAR INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 225. QATAR INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. QATAR INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 281. INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 282. INTRAVENOUS SYSTEM ACCESS DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Intravenous System Access Devices Market was valued at USD 4.54 billion in 2023 and is projected to grow to USD 4.83 billion in 2024, with a CAGR of 6.50%, reaching USD 7.06 billion by 2030.

In the ever-evolving landscape of healthcare, intravenous system access devices have emerged as pivotal components in facilitating effective patient care. This report delves into the market dynamics that have redefined the role of these devices, highlighting the interplay of technological advancements, regulatory shifts, and evolving patient needs. Over the past decade, the increasing prevalence of chronic diseases, the demand for minimally invasive procedures, and the expansion of healthcare services have driven significant innovation in this segment.

Understanding the technological and clinical implications is essential to appreciate how these devices contribute to improved treatment outcomes. With a focus on patient safety, operational efficiency, and cost-effectiveness, this comprehensive analysis offers insights into current market trends, emerging innovations, and the strategic importance of these devices. As the market continues to mature, stakeholders are called upon to balance clinical efficacy with operational ease, further reinforcing the essential nature of well-integrated intravenous access solutions in modern healthcare practices.

The following sections provide an in-depth view of transformative shifts in the landscape, detailed segmentation insights, and regional market trends. In doing so, they offer a roadmap for actionable recommendations, ensuring industry leaders are well-equipped to navigate and capitalize on forthcoming opportunities.

Transformative Shifts Reshaping the Intravenous Access Device Landscape

Over recent years, the market for intravenous system access devices has experienced transformative shifts that have redefined industry parameters. Technological breakthroughs have endowed manufacturers with the tools to develop devices that are not only safer and more effective but also tailor-made to meet the growing complexity of modern healthcare. The integration of advanced materials, smart monitoring systems, and digital interfaces has facilitated real-time patient monitoring, reducing complications and enhancing clinical outcomes.

This evolution is further bolstered by a surge in research and development activities, backed by regulatory incentives and a global focus on patient-centric care. Healthcare institutions and providers are increasingly embracing integrated approaches that link diagnostic data to therapeutic outcomes, thereby ensuring that every device supports both clinical precision and seamless usability. As the landscape transforms, manufacturers are prompted to innovate continuously, ensuring that their products remain ahead of the curve in terms of safety, performance, and compliance. This dynamic environment not only heightens competitive pressures but also drives collaboration among industry stakeholders, fostering an ecosystem where innovation thrives and market standards are continuously elevated.

The convergence of these factors underscores a broader shift towards sustainable healthcare solutions that are responsive to rapid technological changes and evolving patient care protocols.

Key Insights on Market Segmentation Approaches Driving Strategic Advantages

The market research rigorously investigates segmentation strategies that enable stakeholders to pinpoint growth opportunities and tailor solutions to diverse clinical requirements. One primary segmentation is based on device type, wherein the market is comprehensively studied across central intravenous access and peripheral intravenous access. Within the central category, further differentiation is achieved through implantable devices, non-tunneled catheters, peripherally inserted central catheters, as well as tunneled and cuffed central catheters. The peripheral category examines midline catheters alongside the widely used PIV catheters.

Additional segmentation examines the technological aspect by categorizing systems into closed, integrated, and open platforms, ensuring that each technological nuance is aligned with clinical demands. Moreover, the application-based segmentation encompasses a range of clinical uses such as blood transfusion, diagnostic testing, drug administration, and fluid as well as nutritional support, reflecting the device's versatility in clinical practice. Finally, segmentation by end user accounts for variations across ambulatory surgical centers, homecare settings including long-term care facilities, and hospitals and clinics. This multi-layered segmentation approach provides deep insights into market behavior, highlighting the tailored strategies that can be implemented to address specific clinical and operational challenges.

Based on Device Type, market is studied across Central Intravenous Access and Peripheral Intravenous Access. The Central Intravenous Access is further studied across Implantable Devices, Non-tunneled Catheters, Peripherally Inserted Central Catheter, and Tunneled & Cuffed Central Catheter. The Peripheral Intravenous Access is further studied across Midline Catheter and PIV Catheter.

Based on Technology, market is studied across Closed System, Integrated System, and Open System.

Based on Application, market is studied across Blood Transfusion, Diagnostic Testing, Drug Administration, and Fluid & Nutritional Support.

Based on End User, market is studied across Ambulatory Surgical Centers, Homecare Settings & Long-term Care Facilities, and Hospitals & Clinics.

Global Perspectives: Key Regional Insights Across Major Markets

An essential component of the market analysis involves a detailed regional breakdown that underscores the disparities and opportunities unique to each geographic area. The market dynamics in the Americas are characterized by a robust healthcare infrastructure and a continual demand for advanced medical technologies. This region exhibits a high rate of adoption of next-generation devices, spurred by proactive regulatory frameworks and significant investment in healthcare innovations.

In the combined region of Europe, Middle East, and Africa, varied economic landscapes converge to create a complex yet promising market. European markets benefit from well-established healthcare systems, while emerging opportunities in the Middle Eastern and African regions are driven by increased healthcare investments and reform initiatives aimed at modernizing clinical practices.

Across the Asia-Pacific region, rapid economic growth coupled with an expanding healthcare infrastructure has made it one of the fastest-growing markets. The diverse patient demographics and increased awareness of advanced medical procedures have led to a surge in the adoption of technologically advanced intravenous access devices. These regional insights illuminate the strategic importance of localized approaches in market penetration and growth, ensuring that device developers and healthcare providers can craft regionally appropriate strategies that align with both the economic and clinical realities of their respective markets.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Industry Players and Their Strategic Edge

The competitive landscape in the intravenous system access devices market is characterized by the presence of several leading companies that continue to set industry benchmarks. Dominant players include Access Vascular, Inc., Angiplast Private Limited, and Argon Medical Devices, Inc., each of which brings a wealth of experience and cutting-edge innovation to the table. The influence of B. Braun SE, Baxter International Inc., and Becton, Dickinson and Company is evident in their expansive product portfolios and strong global presence.

Other key contributors such as Delta Med S.p.A., Disposafe Health and Life Care Ltd., and FAS United Medical Company emphasize the commitment to quality and reliability of their products. Fresenius SE & Co. KGaA, along with Hangzhou Fushan Medical Appliances Co., LTD., and Harsoria Healthcare Pvt Ltd, have invested significantly in research and development, ensuring that their offerings remain at the forefront of clinical utility. The market is further bolstered by innovative contributions from I-V Access Technology, Inc., ICU Medical, Inc. by Otsuka Holdings Co. Ltd., Kimal PLC, and companies like Medilivescare Manufacturing Private Limited, Medivac Surgical Pvt. Ltd., and Medtronic PLC. The competitive arena is rounded out by Narang Medical Limited, Ningbo GreatCare Trading Co., Ltd., Nipro Corporation, Poly Medicure Limited, Teleflex Incorporated, Terumo Corporation, and Vygon SAS.

Collectively, these companies drive the strategic momentum in the market by ensuring that their product innovations meet the high standards of safety, effectiveness, and versatility demanded by the modern healthcare landscape.

The report delves into recent significant developments in the Intravenous System Access Devices Market, highlighting leading vendors and their innovative profiles. These include Access Vascular, Inc., Angiplast Private Limited, Argon Medical Devices, Inc., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Delta Med S.p.A., Disposafe Health and Life Care Ltd., FAS United Medical Company, Fresenius SE & Co. KGaA, Hangzhou Fushan Medical Appliances Co., LTD., Harsoria Healthcare Pvt Ltd, I-V Access Technology, Inc., ICU Medical, Inc. by Otsuka Holdings Co. Ltd., Kimal PLC, Medilivescare Manufacturing Private Limited, Medivac Surgical Pvt. Ltd., Medtronic PLC, Narang Medical Limited, Ningbo GreatCare Trading Co., Ltd., Nipro Corporation, Poly Medicure Limited, Teleflex Incorporated, Terumo Corporation, and Vygon SAS. Actionable Recommendations for Industry Leaders: Strategic Moves for Market Dominance

For industry leaders looking to capitalize on emerging opportunities in the intravenous system access devices market, a number of actionable strategies emerge from the analysis. First, a focus on continuous innovation is paramount. Companies should invest in R&D and collaborate with clinical experts to refine device performance, ensuring that new products are not only aligned with current clinical needs but also anticipate future trends. Embracing state-of-the-art manufacturing processes and quality control measures will further enhance the safety and reliability of devices.

Second, diversification of product portfolios remains a critical measure to mitigate risk and tap into a broader array of clinical applications. Integrating insights from the segmented market, firms can design products that cater to various device types, technologies, and clinical applications. Such a tailored approach allows companies to address the needs of diverse end users, ranging from ambulatory surgical centers to expansive hospital networks, ultimately strengthening market position.

In addition, forging strategic alliances and partnerships, especially in underpenetrated regional markets, will enable companies to leverage local expertise and distribution networks. This collaboration can also foster innovation through shared research and pooled resources, paving the way for new product developments and enhanced customer services.

Finally, maintaining a proactive stance regarding regulatory compliance and quality assurance will not only safeguard the market entry of new products but also build customer trust over the long term. These recommendations serve as a concrete framework for industry leaders to secure a competitive edge and drive sustained growth in an increasingly dynamic market environment.

Conclusion: Navigating the Future of Intravenous System Access Device Innovation

In summary, the market for intravenous system access devices continues to evolve, driven by a confluence of technological innovation, dynamic market segmentation, and the growth of global healthcare infrastructure. The detailed analysis presented herein underscores that advancements in device design, technological integration, and improved patient safety protocols are at the heart of this transformation. The synthesis of segmentation insights further emphasizes the strategic importance of tailoring devices to specific clinical demands and operational needs.

As market players navigate through evolving regional dynamics and competitive pressures, the future is clearly oriented toward a more integrated and technology-driven approach to patient care. The insights derived from this study provide a strategic roadmap for companies to align their product development and marketing strategies with emerging trends. By focusing on innovation, deepening regional market penetration, and forming cross-industry collaborations, stakeholders can unlock significant value and drive enhanced clinical outcomes in the long term.

This comprehensive outlook not only highlights the key drivers of market growth but also provides a versatile framework to anticipate and respond to future challenges in a proactive manner.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of chronic diseases worldwide
    • 5.1.1.2. Burgeoning outpatient and home healthcare services
    • 5.1.1.3. Increasing medical tourism in developing regions
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with advanced intravenous system access devices and product recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Strategic alliances among healthcare providers and manufacturers
    • 5.1.3.2. Technological innovation in minimally invasive procedures
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory policies and approval requirements, along with limited reimbursement
• 5.2. Market Segmentation Analysis
  • 5.2.1. Device Type: Versatility and ease of use for short-term treatments drives the usage of peripheral intravenous access
  • 5.2.2. Technology: Advanced capabilities in improving healthcare delivery efficiency and enhancing patient safety drives the adoption of integrated system
  • 5.2.3. Application: Vital importance of IV drug administration in modern healthcare
  • 5.2.4. End User: Pivotal role in a broad range of medical treatments and procedures in hospitals and clinics increases the need for intravenous system access devices
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Intravenous System Access Devices Market, by Device Type

• 6.1. Introduction
• 6.2. Central Intravenous Access
  • 6.2.1. Implantable Devices
  • 6.2.2. Non-tunneled Catheters
  • 6.2.3. Peripherally Inserted Central Catheter
  • 6.2.4. Tunneled & Cuffed Central Catheter
• 6.3. Peripheral Intravenous Access
  • 6.3.1. Midline Catheter
  • 6.3.2. PIV Catheter

7. Intravenous System Access Devices Market, by Technology

• 7.1. Introduction
• 7.2. Closed System
• 7.3. Integrated System
• 7.4. Open System

8. Intravenous System Access Devices Market, by Application

• 8.1. Introduction
• 8.2. Blood Transfusion
• 8.3. Diagnostic Testing
• 8.4. Drug Administration
• 8.5. Fluid & Nutritional Support

9. Intravenous System Access Devices Market, by End User

• 9.1. Introduction
• 9.2. Ambulatory Surgical Centers
• 9.3. Homecare Settings & Long-term Care Facilities
• 9.4. Hospitals & Clinics

10. Americas Intravenous System Access Devices Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Intravenous System Access Devices Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Intravenous System Access Devices Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Terumo Interventional Systems expands portfolio with R2P NaviCross catheter launch in U.S.
  • 13.3.2. ICU Medical and Otsuka Pharmaceuticals forge joint venture to increase IV solutions in North America
  • 13.3.3. B. Braun Medical receives FDA clearance for Introcan Safety 2 Deep Access IV Catheter
  • 13.3.4. Poly Medicure's INR 750 crore million investment to expand its manufacturing facilities
  • 13.3.5. BD's strategic acquisition of Edwards Lifesciences' critical care unit
  • 13.3.6. Access Vascular unveils revolutionary HydroGUIDE technology to enhance catheter placement
  • 13.3.7. Nipro invests USD 397.8 million in North Carolina facility to increase local manufacturing and sustainability
  • 13.3.8. Merck expands its Shanghai M Lab to enhance collaborative innovation in biopharmaceutical development and production
  • 13.3.9. B. Braun Canada launches Introcan Safety 2 IV catheter
  • 13.3.10. BD introduces blood draw procedures with next-generation needle-free technology and catheter integration
• 13.4. Strategy Analysis & Recommendation
  • 13.4.1. Becton, Dickinson and Company
  • 13.4.2. B. Braun SE
  • 13.4.3. ICU Medical, Inc. by Otsuka Holdings Co. Ltd.
  • 13.4.4. Nipro Corporation

Companies Mentioned

• 1. Access Vascular, Inc.
• 2. Angiplast Private Limited
• 3. Argon Medical Devices, Inc.
• 4. B. Braun SE
• 5. Baxter International Inc.
• 6. Becton, Dickinson and Company
• 7. Delta Med S.p.A.
• 8. Disposafe Health and Life Care Ltd.
• 9. FAS United Medical Company
• 10. Fresenius SE & Co. KGaA
• 11. Hangzhou Fushan Medical Appliances Co., LTD.
• 12. Harsoria Healthcare Pvt Ltd
• 13. I-V Access Technology, Inc.
• 14. ICU Medical, Inc. by Otsuka Holdings Co. Ltd.
• 15. Kimal PLC
• 16. Medilivescare Manufacturing Private Limited
• 17. Medivac Surgical Pvt. Ltd.
• 18. Medtronic PLC
• 19. Narang Medical Limited
• 20. Ningbo GreatCare Trading Co., Ltd.
• 21. Nipro Corporation
• 22. Poly Medicure Limited
• 23. Teleflex Incorporated
• 24. Terumo Corporation
• 25. Vygon SAS